Inphi Corporation Prices Offering of $250.0 Million of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Inphi Corporation Prices Offering of $250.0 Million of Convertible Senior Notes

SANTA CLARA, CA--(Marketwired - Sep 7, 2016) - Inphi Corporation (NYSE: IPHI) today announced the pricing of $250.0 million aggregate principal amount of 0.75% convertible senior notes due 2021 (the "notes") in a private placement to qualified institutional buyers pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The size of the offering was increased from the previously announced $200.0 million aggregate principal amount. Inphi granted the initial purchasers of the notes a 13-day option to purchase up to an additional $37.5 million aggregate principal amount of notes on the same terms and conditions. The sale of the notes is scheduled to close on September 12, 2016, subject to satisfaction of customary closing conditions.

Inphi estimates that the net proceeds from this offering will be approximately $243.1 million, after deducting the initial purchasers' discount and estimated offering expenses payable by Inphi, and assuming no exercise of the initial purchasers' option to purchase additional notes. Inphi intends to use a portion of the net proceeds from the offering of the notes to pay the cost of certain capped call transactions (described below). Inphi intends to use the remainder of the net proceeds from the offering of the notes for general corporate purposes, including financing potential acquisitions and other strategic transactions. However, Inphi currently has no commitments with respect to any such acquisitions or other strategic transactions.

When issued, the notes will be unsecured, senior obligations of Inphi, and will pay interest semi-annually at a rate of 0.75% per year, and will not be redeemable prior to maturity. Prior to March 1, 2021, the notes will be convertible only under certain circumstances and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The initial conversion rate for the notes will be 17.7508 shares per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $56.34 per share, and will be subject to adjustment upon the occurrence of certain events. The initial conversion price represents a conversion premium of approximately 35% over the last reported sale price of $41.73 per share of Inphi's common stock on The New York Stock Exchange on September 6, 2016. Inphi will settle conversions of the notes by paying or delivering, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at its election. In addition, holders may require Inphi to repurchase their notes upon the occurrence of a fundamental change (as defined in the indenture governing the notes) at a purchase price equal to the principal amount thereof plus accrued and unpaid interest to, but excluding, the repurchase date.

If the initial purchasers exercise their option to purchase additional notes, Inphi intends to use the resulting additional proceeds of the sale of the additional notes to pay the cost of entering into additional capped call transactions and for general corporate purposes, including financing potential acquisitions and other strategic transactions.

In connection with the pricing of the notes, Inphi entered into privately negotiated capped call transactions with certain of the initial purchasers and/or their affiliates (the "option counterparties"). The capped call transactions are expected generally to reduce the potential dilution to Inphi's common stock upon any conversion of the notes and/or offset the cash payments Inphi is required to make in excess of the principal amount upon conversion of the notes in the event that the market price of Inphi's common stock is greater than the strike price of the capped call transactions, which initially corresponds to the initial conversion price of the notes or $56.34 per share, with such reduction subject to a cap based on the cap price of the capped call transactions. The cap price of the capped call transactions will initially be approximately $73.0275 per share, which represents a premium of 75% over the last reported sale price of Inphi's common stock on September 6, 2016, and is subject to certain adjustments under the terms of the capped call transactions. The cost of the capped call transactions will be $19.6 million on the issuance of $250.0 million in notes, assuming no exercise of the initial purchasers' option. If the option is exercised, then Inphi will purchase additional capped call coverage on the additional notes to be issued.

Inphi has been advised by the option counterparties that in connection with establishing their initial hedge of the capped call transactions, the option counterparties and/or their respective affiliates will enter into various derivative transactions with respect to Inphi's common stock concurrently with or shortly after the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Inphi's common stock or the notes at that time, and could result in a higher effective conversion price for the notes.

In addition, Inphi has been advised by the option counterparties that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Inphi's common stock and/or purchasing or selling Inphi's common stock in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so during any observation period related to a conversion of the notes). This activity could also cause or avoid an increase or a decrease in the market price of Inphi's common stock or the notes, which could affect the ability of noteholders to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of the notes, it could affect the amount and value of the consideration that noteholders will receive upon conversion of the notes.

Morgan Stanley and J.P. Morgan are acting as joint book-running managers of this offering. Stifel is acting as lead manager and Needham & Company, Craig-Hallum Capital Group and Roth Capital Partners are acting as co-managers for the offering.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful. The notes and the shares of Inphi's common stock issuable upon conversion of the notes, if any, have not been registered under the Securities Act or the securities laws of any other jurisdiction and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from such registration requirements.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected closing date of the offering and the intended use of net proceeds from the offering. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including risks related to whether Inphi will be able to satisfy the conditions required to close the sale of the notes and the fact that Inphi's management will have broad discretion in the use of the proceeds from any sale of the notes, and other risks detailed from time to time in Inphi's filings with the Securities and Exchange Commission, including its Current Report on Form 8-K dated September 6, 2016. All forward-looking statements in this press release are based on information available to Inphi as of the date hereof, and Inphi does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

Corporate Contact: Kim Markle Inphi 408-217-7329 kmarkle@inphi.com Investor Contact: Deborah Stapleton 650-815-1239 deb@stapleton.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Data Center Transformers on the Brink of a Boom

Updated Category News Views 272

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Continue Reading
Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 50

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
Essity's SEK 850m Bet: Expanding Lilla Edet Facility

Updated Category News Views 99

Essity Doubling Down on Hygiene Hygiene is something you can't compromise on, and Essity gets that. They're shelling out a cool SEK 850 million into their production facility at Lilla Edet in Sweden—no small change, even in the grand scheme of corporate investment. Why the Massive Investment? It's not just about throwing money around; this move is strategic. Essity’s...

Continue Reading
OI Investors Crack Down: Class Action Filing Looms

Updated Category News Views 183

O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 24

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Eve Air Mobility's Vector System Proves Its Worth

Updated Category News Views 84

Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 107

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
SciGround Launches: A Game-Changer in Research Verification

Updated Category News Views 148

Unshackling Research Verification from the Model Folks, here's the big one—Licklider, Inc. from Tokyo lobbed a curveball with their new player in town: SciGround. This platform takes the reins on mathematically verifying AI-driven research, which is something you'll want to keep an eye on if you're at all interested in AI or research replication. Why SciGround Gets My...

Continue Reading
JardogsHealth Taps Industry Titans for Growth Council

Updated Category News Views 99

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Continue Reading
Dahua's Pro Challenge 2026: Bridging Expertise Globally

Updated Category News Views 90

Celebrating Global Installer Expertise Dahua Technology took to the stage in Hangzhou for the Pro Challenge 2026, a shindig pulling installer partners from every corner of the globe. This wasn't just a tech jamboree; it was a tip of the hat to those on the ground who make Dahua's AIoT solutions tick. You know the drill: hands-on demos, tech showcases, and a whole lot of...

Continue Reading

Top 5 Most Recently Viewed Articles

AI’s Dual Nature: Growth Potential or Path to Collapse?

Updated Category News Views 242

The Dichotomy of AI: Catalyst for Growth or Collapse? Yes, AI is a catalyst, though what it catalyzes remains uncertain. The prevailing narrative suggests that our foremost challenge is the need for affordable energy to support the burgeoning data centers of AI technology. Fortunately, solutions are emerging, including the construction of modular nuclear power plants and...

Continue Reading
Ponche Kuba Refreshes Its Look While Keeping Original Flavor

Updated Category News Views 280

Exciting New Look for Ponche Kuba Today marks an exciting chapter in the world of liqueurs as Ponche Kuba unveils its new packaging design, an evolution of its iconic Caribbean rum cream liqueur. Since its inception in 1942 by Don Jaime A. J. Sprock, Ponche Kuba has maintained a loyal following due to its unique flavor and quality. Although the aesthetic has transformed,...

Continue Reading
Unlocking Crypto Success: Double Bonuses and 100x Leverage

Updated Category News Views 129

BexBack Introduces Exciting Crypto Trading Offers BexBack is revolutionizing the cryptocurrency trading landscape with dynamic offers designed for traders looking to capitalize on recent market volatility. Following significant developments in the industry, BexBack has stepped up to provide traders with exceptional options, making it easier than ever to start trading....

Continue Reading
Innovative Partnership Between eMolecules and Optic for Drug Discovery

Updated Category News Views 75

Transforming Drug Discovery with AI Collaboration In an exciting development for the pharmaceutical industry, eMolecules, a leading chemical sourcing company, has joined forces with Optic, a digital biology firm. This collaboration aims to revolutionize the drug discovery process by leveraging the power of artificial intelligence. Together, these companies are creating a...

Continue Reading
Vivani Medical Advances Canine Health with Expanded Collaboration

Updated Category News Views 214

Collaborative Efforts to Enhance Canine Metabolic Health Vivani Medical, Inc. and Okava Pharmaceuticals, Inc. have announced an exciting expansion of their partnership, aiming to enhance the metabolic health and longevity of dogs. With a mutual vision for veterinary medicine, the collaboration focuses on the development of OKV-119, a long-acting GLP-1 therapy designated...

Continue Reading